目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. DNA & Gene Chip Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. DNA & Gene Chip Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. DNA & Gene Chip Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DNA & Gene Chip Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Instrumentation
4.4.1. Instrumentation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. DNA & Gene Chip Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DNA & Gene Chip Market: Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Oligonucleotide DNA Microarrays
5.3.1. Oligonucleotide DNA Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Complementary DNA Microarrays
5.4.1. Complementary DNA Microarrays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. BAC Clone Chips
5.5.1. BAC Clone Chips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. DNA & Gene Chip Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. DNA & Gene Chip Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Cancer Diagnosis & Treatment
6.3.1. Cancer Diagnosis & Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Gene Expression
6.4.1. Gene Expression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Genotyping
6.5.1. Genotyping Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Genomics
6.6.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Drug Discovery
6.7.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Agricultural Biotechnology
6.8.1. Agricultural Biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. DNA & Gene Chip Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. DNA & Gene Chip Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Academic & Government Research Institutes
7.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Hospitals and Diagnostics Centers
7.4.1. Hospitals and Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Biotechnology Pharmaceutical Companies
7.5.1. Biotechnology Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. DNA & Gene Chip Market: Regional Estimates & Trend Analysis
8.1. DNA & Gene Chip Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait DNA & Gene Chip Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Agilent Technologies
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Illumina, Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Revvit
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Arrayit Corporation
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Macrogen, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Asper Biotech
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. CapitalBio Technology Co., Ltd.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Greiner Bio-One International GmbH
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Microarrays Inc.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Biodiscovery LLC
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Oxford Gene Technology IP Limited
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
9.4.13. TOSHIBA HOKUTO ELECTRONICS CORPORATION
9.4.13.1. Participant’s Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Recent Developments/ Strategic Initiatives
9.4.14. Savyon Diagnostics
9.4.14.1. Participant’s Overview
9.4.14.2. Financial Performance
9.4.14.3. Product Benchmarking
9.4.14.4. Recent Developments/ Strategic Initiatives
9.4.15. Applied Micro Arrays
9.4.15.1. Participant’s Overview
9.4.15.2. Financial Performance
9.4.15.3. Product Benchmarking
9.4.15.4. Recent Developments/ Strategic Initiatives
9.4.16. BIOMÉRIEUX
9.4.16.1. Participant’s Overview
9.4.16.2. Financial Performance
9.4.16.3. Product Benchmarking
9.4.16.4. Recent Developments/ Strategic Initiatives